Literature DB >> 12241111

Failure of radiation therapy for brain involvement in Erdheim Chester disease.

Mario Mascalchi1, Patrizia Nencini, Marco Nistri, Cristina Sarti, Riccardo Santoni.   

Abstract

A patient with suprasellar and brain stem involvement in Erdheim Chester disease (ECD) underwent magnetic resonance (MR) imaging and proton MR spectroscopy (1H MRS) of the ventral pons before and 1, 4 and 18 months after external whole-brain (24 Gy) radiotherapy. By revealing a decrease of the N-acetyl-aspartate/choline ratio in the pons, 1H MR spectroscopy anticipated lesions growth on MR imaging. In line with the results in four patients reported in the literature, our observation indicates that external radiation therapy is not effective for intracranial involvement in ECD.

Entities:  

Mesh：

Year:  2002        PMID： 12241111     DOI： 10.1023/a:1019649201324

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  14 in total

1.  Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.

Authors:  L L Wald; S J Nelson; M R Day; S E Noworolski; R G Henry; S L Huhn; S Chang; M D Prados; P K Sneed; D A Larson; W M Wara; M McDermott; W P Dillon; P H Gutin; D B Vigneron
Journal:  J Neurosurg       Date:  1997-10       Impact factor: 5.115

2.  Erdheim-Chester disease: MR of intraaxial and extraaxial brain stem lesions.

Authors:  R Martinez
Journal:  AJNR Am J Neuroradiol       Date:  1995-10       Impact factor: 3.825

3.  Langerhans cell histiocytosis with involvement of the pons: case report.

Authors:  A Vourtsi; A Papadopoulos; L A Moulopoulos; J Xenellis; L Vlahos
Journal:  Neuroradiology       Date:  1998-03       Impact factor: 2.804

Review 4.  Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases.

Authors:  C Veyssier-Belot; P Cacoub; D Caparros-Lefebvre; J Wechsler; B Brun; M Remy; B Wallaert; H Petit; A Grimaldi; B Wechsler; P Godeau
Journal:  Medicine (Baltimore)       Date:  1996-05       Impact factor: 1.889

5.  Neuroradiologic aspects of Chester-Erdheim disease.

Authors:  D Caparros-Lefebvre; J P Pruvo; M Rémy; B Wallaert; H Petit
Journal:  AJNR Am J Neuroradiol       Date:  1995-04       Impact factor: 3.825

6.  Systemic histiocytosis presenting as multiple sclerosis.

Authors:  M E Smith; D A Katz; J O Harris; J A Frank; C V Kufta; D E McFarlin
Journal:  Ann Neurol       Date:  1993-05       Impact factor: 10.422

7.  Cerebral manifestation of Erdheim-Chester disease: clinical and radiologic findings.

Authors:  S Bohlega; J Alwatban; A Tulbah; S M Bakheet; J Powe
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

8.  Neurological manifestations of Erdheim-Chester disease.

Authors:  R A Wright; R C Hermann; J E Parisi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

9.  Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging.

Authors:  A Bizzi; B Movsas; G Tedeschi; C L Phillips; P Okunieff; J R Alger; G Di Chiro
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

10.  Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images.

Authors:  R D Tien; R C Brasch; D E Jackson; W P Dillon
Journal:  Radiology       Date:  1989-09       Impact factor: 11.105
View more
  13 in total

Review 1.  Erdheim-Chester disease as cause of end-stage renal failure: a case report and review of the literature.

Authors:  Jose Emilio Sanchez; Carmen Mora; Manuel Macia; Juan F Navarro
Journal:  Int Urol Nephrol       Date:  2010-03-16       Impact factor: 2.370

Review 2.  Erdheim-Chester Disease: a comprehensive review of the literature.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Yehuda Shoenfeld
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

3.  Late-onset sporadic ataxia, pontine lesion, and retroperitoneal fibrosis: a case of Erdheim-Chester disease.

Authors:  E Salsano; M Savoiardo; S Nappini; E Maderna; B Pollo; D Chinaglia; U Guerra; G Finocchiaro; D Pareyson
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

Review 4.  Cerebral Erdheim-Chester disease: case report and review of the literature.

Authors:  Stefan Weidauer; Sebastian von Stuckrad-Barre; Edgar Dettmann; Friedhelm E Zanella; Heinrich Lanfermann
Journal:  Neuroradiology       Date:  2003-02-21       Impact factor: 2.804

5.  Erdheim Chester - a rare disease with unique endoscopic features.

Authors:  Gil Ben-Yaakov; Daniela Munteanu; Ignacio Sztarkier; Alexander Fich; Doron Schwartz
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

6.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

Review 7.  Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature.

Authors:  Florence Lachenal; François Cotton; Hélène Desmurs-Clavel; Julien Haroche; Hervé Taillia; Nadine Magy; Mohamed Hamidou; Juan Salvatierra; Jean-Charles Piette; Denis Vital-Durand; Hugues Rousset
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

8.  Erdheim-Chester disease: atypical presentation of a rare disease.

Authors:  Cristian Ricardo Calandra; Ariel Bustos; Florencia Falcon; Naomi Arakaki
Journal:  BMJ Case Rep       Date:  2017-10-11

Review 9.  Radiotherapy for Erdheim-Chester disease.

Authors:  Katsunori Matsui; Yasushi Nagata; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

10.  Unusual manifestation of Erdheim-Chester disease.

Authors:  Antony Pan; Terence Doyle; Martin Schlup; Ralf Lubcke; Michael Schultz
Journal:  BMC Gastroenterol       Date:  2011-06-22       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.